High prevalence of subclinical cardiovascular abnormalities in patients with systemic lupus erythematosus in spite of a very low clinical damage index

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 19, Issue 4, 2009, Pages 234-240

  Palmieri, V ^a,b   Migliaresi, P ^b   Orefice, M ^c   Lupo, T ^b   Di Minno, M N D ^a   Valentini, G ^b   Celentano, A ^a,b  

^a Ospedale dei Pellegrini   (Italy)

^b FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cardiovascular; Echocardiography; Endothelium; inflammation; Organ damage

Indexed keywords

DIAGNOSTIC AGENT; GLYCERYL TRINITRATE; VASODILATOR AGENT;

ADOLESCENT; ADULT; AORTA VALVE REGURGITATION; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CAROTID ARTERY DISEASE; COMPARATIVE STUDY; COMPLIANCE (PHYSICAL); DOPPLER ECHOCARDIOGRAPHY; DOPPLER FLOWMETRY; ECHOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR ENDOTHELIUM; VASODILATATION;

ADOLESCENT; ADULT; AORTIC VALVE INSUFFICIENCY; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; COMPLIANCE; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NITROGLYCERIN; PREVALENCE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; ULTRASONOGRAPHY, DOPPLER; VASODILATION; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 65349100819     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2008.09.009     Document Type: Article

References (50)

1. Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Arthritis Rheum 42 (1999) 1785-1796
2. Doria A., Iaccarino L., Sarzi-Puttini P., Atzeni F., Turriel M., and Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus 14 (2005) 683-686
3. Gladman D., Ginzler E., Goldsmith C., Fortin P., Liang M., Urowitz M., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39 (1996) 363-369
4. Gladman D.D., Goldsmith C.H., Urowitz M.B., Bacon P., Fortin P., Ginzler E., et al. The Systemic Lupus International Collaborating Clinics/American. J Rheumatol 27 (2000) 373-376
5. Nived O., Jonsen A., Bengtsson A.A., Bengtsson C., and Sturfelt G. High predictive value of the Systemic Lupus International. J Rheumatol 29 (2002) 1398-1400
6. Devereux R.B., and Alderman M.H. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation 88 (1993) 1444-1455
7. Psaty B.M., Furberg C.D., Kuller L.H., Bild D.E., Rautaharju P.M., Polak J.F., et al. Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: the Cardiovascular Health Study. Arch Intern Med 159 (1999) 1339-1347
8. Esdaile J.M., Abrahamowicz M., Grodzicky T., Li Y., Panaritis C., du Berger R., et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44 (2001) 2331-2337
9. Rahman P., Urowitz M.B., Gladman D.D., Bruce I.N., and Genest Jr. J. Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J Rheumatol 26 (1999) 2363-2368
10. Urowitz M.B., Ibanez D., and Gladman D.D. Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J Rheumatol 34 (2007) 70-75
11. Manzi S., Kuller L.H., Edmundowicz D., and Sutton-Tyrrell K. Vascular imaging: changing the face of cardiovascular research. Lupus 9 (2000) 176-182
12. Hallegua D.S., and Wallace D.J. How accelerated atherosclerosis in SLE has changed our management of the disorder. Lupus 9 (2000) 228-231
13. Wajed J., Ahmad Y., Durrington P.N., and Bruce I.N. Prevention of cardiovascular disease in systemic lupus erythematosus-proposed guidelines for risk factor management. Rheumatology (Oxford) 43 (2004) 7-12
14. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 (1997) 1725
15. Palmieri V., Arnett D.K., Roman M.J., Liu J.E., Bella J.N., Oberman A., et al. Appetite suppressants and valvular heart disease in a population-based sample: the HyperGEN study. Am J Med 112 (2002) 710-715
16. Celentano A., Palmieri V., Arezzi E., Mureddu G.F., Sabatella M., Di Minno G., et al. Gender differences in left ventricular chamber and midwall systolic function in normotensive and hypertensive adults. J Hypertens 21 (2003) 1415-1423
17. Palmieri V., Storto G., Arezzi E., Pellegrino T., Mancini M., Di Minno G., et al. Relations of left ventricular mass and systolic function to endothelial function and coronary flow reserve in healthy, new discovered hypertensive subjects. J Hum Hypertens 19 (2005) 941-950
18. Diagnosis and classification of diabetes mellitus. Diabetes Care 29 Suppl. 1 (2006) S43-S48
19. Palmieri V., Migliaresi P., Di Minno G., Valentini G., and Celentano A. Preclinical and prognostically relevant cardiovascular disease burden in systemic lupus erythematosus with low clinical damage index. Nutr Metab Cardiovasc Dis 18 (2008) e23-e25
20. Roman M.J., Naqvi T.Z., Gardin J.M., Gerhard-Herman M., Jaff M., and Mohler E. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiogr 19 (2006) 943-954
21. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
22. Palmieri V., Okin P.M., Bella J.N., Gerdts E., Wachtell K., Gardin J., et al. Echocardiographic wall motion abnormalities in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE Study. Hypertension 41 (2003) 75-82
23. Devereux R.B., Roman M.J., Paranicas M., O'Grady M.J., Wood E.A., Howard B.V., et al. Relations of Doppler stroke volume and its components to left ventricular stroke volume in normotensive and hypertensive American Indians: the Strong Heart Study. Am J Hypertens 10 (1997) 619-628
24. Devereux R.B., Roman M.J., Palmieri V., Liu J.E., Lee E.T., Best L.G., et al. Prognostic implications of ejection fraction from linear echocardiographic dimensions: the Strong Heart Study. Am Heart J 146 (2003) 527-534
25. de Simone G., Roman M.J., Koren M.J., Mensah G.A., Ganau A., and Devereux R.B. Stroke volume/pulse pressure ratio and cardiovascular risk in arterial hypertension. Hypertension 33 (1999) 800-805
26. Corretti M.C., Anderson T.J., Benjamin E.J., Celermajer D., Charbonneau F., Creager M.A., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow- mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39 (2002) 257-265
27. Ferrara L.A., Innelli P., Palmieri V., Limauro S., De Luca G., Ferrara F., et al. Effects of different dietary protein intakes on body composition and vascular reactivity. Eur J Clin Nutr 60 (2006) 643-649
28. Kuvin J.T., Patel A.R., Sliney K.A., Pandian N.G., Rand W.M., Udelson J.E., et al. Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. J Am Coll Cardiol 38 (2001) 1843-1849
29. El Magadmi M., Bodill H., Ahmad Y., Durrington P.N., Mackness M., Walker M., et al. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 110 (2004) 399-404
30. Lima D.S., Sato E.I., Lima V.C., Miranda Jr. F., and Hatta F.H. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol 29 (2002) 292-297
31. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
32. Shimbo D., Grahame-Clarke C., Miyake Y., Rodriguez C., Sciacca R., Di Tullio M.R., et al. The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis 192 (2007) 197-203
33. Roman M.J., Shanker B.A., Davis A., Lockshin M.D., Sammaritano L., Simantov R., et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349 (2003) 2399-2406
34. Manzi S., Selzer F., Sutton-Tyrrell K., Fitzgerald S.G., Rairie J.E., Tracy R.P., et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 42 (1999) 51-60
35. Wright S.A., O'Prey F.M., Rea D.J., Plumb R.D., Gamble A.J., Leahey W.J., et al. Microcirculatory hemodynamics and endothelial dysfunction in systemic lupus erythematosus. Arterioscler Thromb Vasc Biol 26 (2006) 2281-2287
36. Roman M.J., Crow M.K., Lockshin M.D., Devereux R.B., Paget S.A., Sammaritano L., et al. Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 56 (2007) 3412-3419
37. Schillaci O., Lagana B., Danieli R., Gentile R., Tubani L., Baratta L., et al. Technetium-99m sestamibi single-photon emission tomography detects subclinical myocardial perfusion abnormalities in patients with. Eur J Nucl Med 26 (1999) 713-717
38. Asanuma Y., Oeser A., Shintani A.K., Turner E., Olsen N., Fazio S., et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 349 (2003) 2407-2415
39. Cicala S., de Simone G., Roman M.J., Best L.G., Lee E.T., Wang W., et al. Prevalence and prognostic significance of wall-motion abnormalities in adults without clinically recognized cardiovascular disease. The Strong Heart Study. Circulation 116 (2007) 143-150
40. Bujan S., Ordi-Ros J., Paredes J., Mauri M., Matas L., Cortes J., et al. Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients. Ann Rheum Dis 62 (2003) 859-865
41. Roldan C.A., Shively B.K., and Crawford M.H. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 335 (1996) 1424-1430
42. Jensen-Urstad K., Svenungsson E., de Faire U., Silveira A., Witztum J.L., Hamsten A., et al. Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease. Lupus 11 (2002) 744-752
43. Roldan C.A., Gelgand E.A., Qualls C.R., and Sibbitt Jr. W.L. Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus. Am J Cardiol 95 (2005) 1441-1447
44. Roldan C.A., Gelgand E.A., Qualls C.R., and Sibbitt Jr. W.L. Valvular heart disease by transthoracic echocardiography is associated with focal brain injury and central neuropsychiatric systemic Lupus Erythematosus. Cardiology 108 (2007) 331-337
45. Molad Y., Levin-Iaina N., Vaturi M., Sulkes J., and Sagie A. Heart valve calcification in young patients with systemic lupus erythematosus: a window to premature atherosclerotic vascular. Atherosclerosis 185 (2006) 406-412
46. Mattace-Raso F.U., van der Cammen T.J., Hofman A., van Popele N.M., Bos M.L., Schalekamp M.A., et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 113 (2006) 657-663
47. Roman M.J., Devereux R.B., Schwartz J.E., Lockshin M.D., Paget S.A., Davis A., et al. Arterial stiffness in chronic inflammatory diseases. Hypertension 46 (2005) 194-199
48. Selzer F., Sutton-Tyrrell K., Fitzgerald S.G., Pratt J.E., Tracy R.P., Kuller L.H., et al. Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. Arthritis Rheum 50 (2004) 151-159
49. Palmieri V., Bella J.N., Arnett D.K., Roman M.J., Oberman A., Kitzman D.W., et al. Aortic root dilatation at sinuses of Valsalva and aortic regurgitation in hypertensive and normotensive subjects: The Hypertension Genetic Epidemiology Network Study. Hypertension 37 (2001) 1229-1235
50. Palmieri V., Roman M.J., Bella J.N., Liu J.E., Best L.G., Lee E.T., et al. Prognostic implications of relations of left ventricular systolic dysfunction with body composition and myocardial energy expenditure: the Strong Heart Study. J Am Soc Echocardiogr 21 (2008) 66-71